To explore the possible mechanism of melatonin’s beneficial effects on NAFLD, we measured mRNA levels of pro-inflammatory makers and the active levels of mitogen-activated protein kinase (MAPK) signaling. This evidence concerns the gene WNK2 and metabolic dysfunction-associated steatotic liver disease.